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To develop a transgenic pig, introduction of foreign genes into fibroblasts is required. In this study, 
Piggybac transposition was used to produce tetracycline dependent gene expressing cloned embryos. 
Red fluorescence proteins (DsRed) combined with tetracycline promoter flanked transposon sequences 
were transfected into fetal fibroblasts, and the transfected cells were used as the donor for somatic cell 
nuclear transfer. Induction of DsRed expression was successfully controlled by doxycycline treatment 
in donor fibroblasts and early stage embryos. In conclusion, this study suggested that Piggybac 
transposition could deliver genes into cells or embryos for developing transgenic pig. 
 






Pigs are one of the valuable animal models for human 
biomedical research, particularly, xeno-transplantation, 
because they have similar characteristics in the size of 
their organs and physiology (Aigner et al., 2010b; Ekser 
et al., 2011; 2012). Hence, for xeno-transplantation, 
transgenesis in pigs is considered as a prerequisite pro-
cess for reducing or removing the immune rejection. 
Since the first transgenic pigs via microinjection were 
born (Hammer et al., 1985), several transgenic pigs have 
been produced by somatic cell nuclear transfer (SCNT). It 
involves a somatic donor cell injected into an enucleated 
oocyte, and then cloned embryos transferred into 
surrogate mothers (Aigner et al., 2010b). Many cloned 
transgenic pigs were derived from plasmid vector or viral 
infection system for knockout or over-expression of the 
target gene (Aigner et al., 2010a, b; Klymiuk et al., 2010). 
Since constitutive expressions of the foreign gene often 
make transgenic animals lethal, it is preferred that the 
target genes are expressed in a temporarily and spatially 
controlled manner.  
To circumvent these problems, methods for inducible 
transgenic systems have been developed, including tetra-
cycline inducible system that has been extensively used 
mostly in rodent animal models (Zhu et al., 2002; Sun et 
al., 2007). 
Recently, a gene delivery system, Piggybac (PB) trans-
position was successfully applied to produce transgenic 
mice (Ding et al., 2005; Nakanishi et al., 2010). In those 
studies, PB transposition delivered genes into transgenic 
mice efficiently.  
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Figure 1. DNA map for inducible DsRed protein in somatic cells or embryos (A). Three plasmid DNA (A-a, -b and -c) transfected into 
fetal fibroblast and then treated with neomycin for removing non-transfected cells. After treating neomycin for 2 weeks, DsRed 
proteins in transfected cells were regulated with or without doxycycline (B, upper panel: under brightness, lower panel: under 
fluorescence). Expression level of mRNA of DsRed using RT-PCR was decreased without doxycycline (C, Lane 1: positive control, 
plasmid DNA, 2: non-transfected cells, 3: without doxycycline before turn on, 4: with doxycycline after 48 h, 5: with doxycycline after 
96 h, 6: without doxycycline after 48 h, 7: without doxycycline after 96 h, 8: without doxycycline after 144 h, Upper panel is for RFP 
expression, band size (435 bps), lower panel is for GAPDH (252 bps). Transfected cells were reprogrammed in enucleated oocytes 




Accordingly, this study investigated the feasibility of 
tetracycline inducible gene expression using PB transpo-




MATERIALS AND METHODS 
 
Basic PB transposition system was provided by Addgene (Plasmid 
#20909, http://www.addgene.org). DsRed was amplified using PCR 




DsRed PCR amplicons through BP and LR recombination 
(Invitrogen, Gaithersburg, USA) were inserted into the expression 
destination vector, PB-TET with a tetracycline inducible promoter 
from Addgene. Three plasmid genes (0.5 μg PB-TET-DsRed, 0.5 
μg PB-CA-rtTA, from Addgene, plasmid #20910 and 1 μg Transpo-
sase) were transfected using Fugene HD (Promega, Wisconsin, 
USA). Fetal fibroblasts from a male miniature fetus were used for 
the transfection. Transfections protocol was based on manufacturer’s 
instruction. Briefly, once growing cells were 50-60% confluent, 
transfection was carried out. Serum-free DMEM (Invitrogen) 
containing a ratio of one to three (DNA: transfection reagent) was 
added as a culture medium. For establishing a stable cell line, 800 
μg/mL neomycin (G418, Gibco, Invitrogen) and 2 μg/mL doxycyc-
line (Sigma-Aldrich,St Louis MO, USA) during two weeks were used 
after transfection for 48 h. After DsRed expressing cells were esta-
blished, the cells were cultured for more 10 days without doxycyc-
line  in order to observe disappearance of DsRed protein under the 





Thereafter, the DsRed expressing cells were used for SCNT 
(Park et al., 2010; Cho et al., 2011). Briefly, immature oocytes were 
cultured in TCM 199 medium supplemented with 10 ng/mL EGF, 
0.57 mM cysteine, 0.91 mM sodium pyruvate, 5 μg/mL insulin, 1% 
(v/v) Pen-Strep (Invitrogen), 0.5 μg/mL follicle stimulating hormone, 
0.5 μg/mL luteinizing hormone and 10% porcine follicular fluid at 
39°C in a humidified atmosphere of 5% CO2 in air; this was done at 
first with gonadotropin-releasing hormone for 22 h and then without 
it for another 22 h. After the maturation of the oocytes, genetic 
materials of oocytes were removed under the nuclear staining and a 
DsRed expressing cell was micro-injected into enucleated oocytes. 
The reconstructed oocytes were fused and electrically activated as 
follows; the fusion medium was 0.26 M mannitol solution containing 
0.5 mM Hepes, 0.1 mM CaCl2 and 0.1 mM MgSO4. Oocytes were 
activated with a single DC pulse of 1.5 kV/cm for 60 μs, utilizing a 
BTX electro-cell Manipulator 2001 (BTX, Inc., San Diego, USA). 
The activated embryos were cultured in PZM5 medium (IFP0410P, 
Funakoshi, Tokyo, Japan) for seven days. 
 
 
RESULTS AND DISCUSSION 
 
To make a stable DsRed expressing cell line, it took two 
weeks from initial transfection. Expression on or off of 
DsRed mRNA or protein using PB transposition in por-
cine fibroblasts worked well in the presence or absence 
of the doxycycline (Figure 1). With the transfected cells, 
123 oocytes for SCNT were used. Developmental ratios 
of two-cell and blastocyst stage from an activated 
reconstructed oocytes were 58.5% (n = 72) and 11.4% (n 
= 14), respectively. When early blastocysts were cultured 
for two more days with doxycycline, the blastocysts 
expressed ubiquitously DsRed in all embryonic cells 
(Figure 1). 
Technically, for delivering a foreign gene, the cDNA 
from the cells or tissues was cloned, sequenced and 
inserted into expression vector with circular form. Before 
the DNA was transfected with several transfection proto-
cols including electroporation, the DNA was linearized 
more efficiently for transferring the gene into the host ge-
nome. However, without linearization, circular form, PB-
DNAs are transposed through “cut-and-paste” mechanism, 
whereby transposase catalyzes the excision of the trans-
poson from one chromosomal site and reinserted 
elsewhere in the genome. Recently, it was shown that PB 
efficiently transposes in human (Owens et al., 2012) and 
mouse cell lines. That could readily mediate the intro-
duction of foreign genes (up to 14 kb) in the mouse germ 
line (Ding et al., 2005). While viral infection and simple 
plasmid transfections have been applied to generate 
cloned transgenic pigs (Hyun et al., 2003; Cho et al., 
2011), the data from this study, transposon using PB 
could be an alternative way to produce transgenic pig 
models.  
In summary, these results demonstrated that PB sys-
tem combined with inducible gene expression by doxy-
cycline can successfully deliver foreign genes (DsRed) 
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